Stuart Milstein, Ph.D.

Stuart Milstein, Ph.D., vice president of platform biology at Korro Bio, brings years of expertise in RNA delivery technology.

Previously, at Alnylam Pharmaceuticals, Stuart established and led the RNAi Lead Development group, which was responsible for the lead development and optimization for all clinical candidates in the Alnylam pipeline. He also initiated work on delivery of siRNAs to the central nervous system and led the CNS delivery platform.

Prior to joining Alnylam, Stuart was a research fellow in the department of Genetics at Harvard Medical School and Dana-Farber Cancer Institute, and received his Ph.D. through the genetics program at Cold Spring Harbor Laboratory and Stony Brook University.